MedTrace Logo

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study

NCT04074460 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 169

Last updated 2022-06-09

No results posted yet for this study

Summary

A multicentre, prospective randomized, active-controlled feasibility trial of volatile-based anaesthesia vs. propofol-based total intravenous anaesthesia to investigate the impact of anaesthesia on long-term (i.e. 5-years) patient cancer outcomes in patients undergoing elective major cancer surgery.

Conditions

  • Cancer, Breast
  • Cancer Colorectal
  • Cancer Prostate
  • Cancer, Lung
  • Cancer Melanoma Skin
  • Cancer, Other

Interventions

DRUG

Propofol

General Anaesthesia

DRUG

isoflurane, sevoflurane or desflurane

General Anaesthesia

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    collaborator OTHER

  • Melbourne Health

    collaborator OTHER

  • The Alfred

    collaborator OTHER

  • Peter MacCallum Cancer Centre, Australia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-27
Primary Completion
2019-10-31
Completion
2020-06-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04074460 on ClinicalTrials.gov